Martine Piccart Selected Research

Martine Piccart Research Topics

Disease

145	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2002
78	Neoplasms (Cancer) 05/2024 - 02/2004
16	Pathologic Complete Response 01/2023 - 01/2010
10	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2007
5	Triple Negative Breast Neoplasms 06/2022 - 07/2014
5	Cardiotoxicity 01/2020 - 01/2003
4	Diarrhea 01/2020 - 04/2008
4	Disease Progression 01/2019 - 08/2012
3	Neutropenia 01/2021 - 01/2006
3	Fatigue 02/2012 - 11/2004
3	Ovarian Neoplasms (Ovarian Cancer) 01/2006 - 01/2002
2	Obesity 01/2023 - 10/2020
2	Overweight 01/2021 - 10/2020
2	Heart Failure 01/2019 - 08/2006
2	Residual Neoplasm 01/2018 - 01/2016
2	Chromosomal Instability (Chromosome Stability) 02/2016 - 06/2012
2	Exanthema (Rash) 01/2016 - 12/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 05/2014
1	Inflammation (Inflammations) 01/2023
1	Lobular Carcinoma 07/2022
1	Brain Neoplasms (Brain Tumor) 06/2022
1	Weight Loss (Weight Reduction) 01/2021
1	Diabetes Mellitus 01/2020
1	Amenorrhea 01/2019
1	Infections 01/2019
1	Wounds and Injuries (Trauma) 01/2019

Drug/Important Bio-Agent (IBA)

42	Trastuzumab (Herceptin)FDA Link 11/2023 - 01/2002
34	Hormones (Hormone)IBA 11/2023 - 04/2008
23	Estrogen ReceptorsIBA 05/2024 - 01/2005
17	human ERBB2 proteinIBA 08/2023 - 01/2010
16	Aromatase InhibitorsIBA 06/2023 - 04/2008
14	Lapatinib (GW572016)FDA Link 11/2023 - 01/2013
14	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 01/2002
13	AnthracyclinesIBA 10/2023 - 12/2002
12	exemestane (Aromasin)FDA Link 10/2020 - 04/2008
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
10	Everolimus FDA Link 02/2016 - 01/2008
9	Phenobarbital (Luminal)FDA Link 10/2021 - 01/2008
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 01/2002
8	Tamoxifen FDA LinkGeneric 06/2023 - 11/2006
8	ErbB Receptors (EGF Receptor)IBA 01/2023 - 08/2006
8	Docetaxel (Taxotere)FDA Link 10/2020 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2004
6	pertuzumabIBA 01/2021 - 07/2017
6	Taxoids (Taxanes)IBA 01/2020 - 12/2002
5	Fulvestrant (Faslodex)FDA Link 01/2022 - 04/2008
5	Capecitabine (Xeloda)FDA Link 10/2020 - 04/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2002
5	Epirubicin (Ellence)FDA LinkGeneric 02/2017 - 12/2002
4	Monoclonal AntibodiesIBA 01/2019 - 01/2002
4	Messenger RNA (mRNA)IBA 10/2014 - 12/2006
3	palbociclibIBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 02/2020 - 01/2011
3	taxaneIBA 01/2020 - 04/2008
3	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2007
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2013
3	Letrozole (Femara)FDA LinkGeneric 01/2019 - 01/2008
3	Fluorouracil (Carac)FDA LinkGeneric 02/2017 - 05/2005
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2024 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 01/2015
2	Indicators and Reagents (Reagents)IBA 06/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2019
2	ParaffinIBA 02/2016 - 08/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2015 - 08/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 02/2004
2	Epidermal Growth Factor (EGF)IBA 02/2014 - 08/2013
2	TOR Serine-Threonine KinasesIBA 08/2013 - 02/2012
2	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 12/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2006 - 02/2004
2	Cisplatin (Platino)FDA LinkGeneric 11/2004 - 01/2002
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023
1	Cadherins (E-Cadherin)IBA 07/2022
1	sacituzumab govitecanIBA 06/2022
1	Thymidine KinaseIBA 01/2022
1	beta-2 Adrenergic ReceptorsIBA 01/2022
1	Complement System Proteins (Complement)IBA 12/2021
1	Adenosine (Adenocard)FDA LinkGeneric 08/2021
1	durvalumabIBA 08/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	olaparibIBA 01/2021
1	abemaciclibIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	Denosumab FDA Link 12/2020
1	PlatinumIBA 10/2020
1	AntidiarrhealsIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	thymidine kinase 1IBA 01/2019
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019

Therapy/Procedure

70	Therapeutics 05/2024 - 01/2002
35	Drug Therapy (Chemotherapy) 10/2023 - 01/2002
22	Neoadjuvant Therapy 11/2023 - 01/2009
14	Adjuvant Chemotherapy 01/2023 - 01/2003
5	Radiotherapy 08/2021 - 02/2004
3	Segmental Mastectomy (Lumpectomy) 01/2024 - 01/2015
2	Immunotherapy 12/2020 - 01/2019
2	Molecular Targeted Therapy 12/2016 - 02/2004
2	Aftercare (After-Treatment) 12/2013 - 05/2013
1	Mastectomy (Mammectomy) 01/2020